The application is directed to in-vitro-reared Plasmodium sporozoites of human host range
wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes …

The application is directed to in vitro-reared Plasmodium sporozoites of human host range
wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes …

Disclosed are substantially purified Plasmodium sporozoites and preparations of
Plasmodium sporozoites substantially separated from attendant non-sporozoite material …

Disclosed are substantially purified Plasmodium sporozoites and preparations of
Plasmodium sporozoites Substantially separated from attendant non-sporozoite material …

Disclosed are substantially purified Plasmodium sporozoites and preparations of
Plasmodium sporozoites Substantially separated from attendant non-sporozoite material …

Disclosed are apparatuses and methods for the production of attenuated aseptic parasites in
haematophagous insects generally, and production of Plasmodium species sporozoites in …

Disclosed are apparatuses and methods for the production of attenuated aseptic parasites in
hematophagous insects gen erally, and production of Plasmodium species sporozoites in …

The invention comprises novel compositions and methods for protecting Subjects against
malaria. The compositions of the invention include aseptic, live attenuated Plasmodium …

A device and method of use for augmenting the extraction of salivary glands from
Plasmodium-infected mosquitoes, where the sporozoite stage of Plasmodium primarily …

Disclosed herein are mutant Plasmodium-species parasites that are genetically attenuated
(GAP). They retain the ability to infect a host and invade host hepatocytes but subsequently …